FDA Issues Safety Statement that SGLT-2 Inhibitors May Cause Diabetic Ketoacidosis

Diabetic ketoacidosis is a complication of diabetes that occurs when the body produces elevated levels of acidic compounds called ketones, often due to a lack of effective insulin action, which can lead to hospitalization, coma, and even death if left untreated.

Read more

Posted in Drugs